Rates of visual field change and functional progression in glaucoma following trabecular microbypass implantation of iStent technologies: a meta-analysis
Background/aim While intraocular pressure (IOP) remains the only modifiable risk factor for glaucoma progression, the ultimate goal of glaucoma management is to preserve patients’ functional vision and quality of life. To this end, minimally invasive glaucoma surgeries (MIGSs) aim to reduce IOP with...
Saved in:
| Main Authors: | Kevin Gillmann, Dana M Hornbeak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-02-01
|
| Series: | BMJ Open Ophthalmology |
| Online Access: | https://bmjophth.bmj.com/content/9/1/e001575.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effectiveness of First-Generation iStent Microbypass Implantation Depends on Initial Intraocular Pressure: 24-Month Follow-Up—Prospective Clinical Trial
by: Joanna Konopińska, et al.
Published: (2020-01-01) -
Five-Year Outcomes of iStent inject Implantation With or Without Phacoemulsification in Eyes with Open-Angle Glaucoma
by: Ricardo Augusto Paletta Guedes, et al.
Published: (2025-04-01) -
Glaukos iStent inject® Trabecular Micro-Bypass Implantation Associated with Cataract Surgery in Patients with Coexisting Cataract and Open-Angle Glaucoma or Ocular Hypertension: A Long-Term Study
by: Pedro Arriola-Villalobos, et al.
Published: (2016-01-01) -
A 2-year longitudinal evaluation of the iStent inject® system for open-angle glaucoma in East Asian eyes
by: Ru Jian Jonathan Teoh, et al.
Published: (2025-01-01) -
Third-Generation Trabecular Micro-Bypass Implantation with Phacoemulsification for Glaucoma
by: Zachary Vest, et al.
Published: (2025-01-01)